Halop, Baby Girl .

HRN: 25-81-27  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/03/2024
AMPICILLIN 250MG (VIAL)
09/03/2024
09/10/2024
IV
140mg
Q12
Noninstitutional Delivery
Waiting Final Action 
09/03/2024
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
09/03/2024
09/10/2024
IV
42mg
Q24
Noninstitutional Delivery
Waiting Final Action 
09/03/2024
ERYTHROMYCIN 0.5%, 3.5G EYE OINTMENT (TUBE)
09/03/2024
09/03/2024
TOPICAL
1 Squint
Once
Newborn Care
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: